Evaluating the value of uPAR of serum and tissue on patients with cervical cancer

Journal of Clinical Laboratory Analysis

Volumn 26, Issue 1, 2012, Pages 16-21

  Jing, Jiexian ^a   Zheng, Shumin ^a   Han, Cunzhi ^a   Du, Lili ^a   Guo, Yongfeng ^a   Wang, Pei ^a  

^a Shanxi Province Tumor Hospital   (China)

Author keywords

Cervical cancer; Serum; Tissue; Urokinase type plasminogen activator receptor (uPAR)

Indexed keywords

UROKINASE RECEPTOR;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; UTERINE CERVIX CANCER; VEIN EMBOLISM; VEIN THROMBOSIS; BLOOD; CARCINOMA; METABOLISM; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; STATISTICS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

ADULT; AGED; CARCINOMA; FEMALE; HUMANS; MIDDLE AGED; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; RETROSPECTIVE STUDIES; STATISTICS AS TOPIC; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84868566409     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20499     Document Type: Article

References (19)

1. Canavan TP, Doshi NR. Cervical cancer. Am Fam Physician 2000;61:1369-1376.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
3. Tamiolakis D, Kalloniatou M, Lambropoulou M, et al. Contribution of combined colposcopy and cytology in cervical pathology. Arch Gynecol Obstet 2005;273:39-42.
4. Jo M, Thomas KS, O'Donnell DM, Gonias SL. Epidermal growth factor receptor-dependent and -independent cell-signaling pathways originating from the urokinase receptor. J Biol Chem 2003;278:1642-1646.
5. Huang S, Armstrong EA, Benavente S, Chinnaiyan P, Harari PM. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): Combining anti-EGFR antibody with tyrosine kinase inhibitor. Cancer Res 2004;64:5355-5362.
6. Guerrero J, Santibanez JF, Gonzalez A, Martinez J. EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases. Exp Cell Res 2004;292:201-208.
7. Van Buren 2nd G, Gray MJ, Dallas NA, et al. Targeting the urokinase plasminogen activator receptor with a monoclonal antibody impairs the growth of human colorectal cancer in the liver. Cancer 2009;115:3360-3368
8. Liu Y, Pixley R, Fusaro M, et al. Cleaved high-molecular-weight kininogen and its domain 5 inhibitmigration and invasion of human prostate cancer cells through the epidermal growth factor receptor pathway. Oncogene 2009;28:2756-2765
9. Hildenbrand R, Schaaf A, Dorn-Beineke A, et al. Tumor stroma is the predominant uPA-, uPAR-, PAI-1-expressing tissue in human breast cancer: prognostic impact. Histol Histopathol 2009;24:869- 877.
10. Barillot I, Horiot JC, Maingon P, et al. Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: Baseline results to compare new strategies. Int JRadiat Oncol Biol Phys 2000;48:189-200.
11. Cao ZY. Changes and thinking in the treatment of cervical cancer. Chin J Obstet Gynecol 2004;39:212-213.
12. Wang P, Zheng SM, Jing JX. The serum and tissue plasminogen activator receptor protein of patients with cervical cancer and its clinical significance. Cancer Res Clin 2008;20:474- 475.
13. Zheng Q, Tang ZY, Xue Q, Shi DR, Song HY, Tang HB. Invasion and metastasis of hepatocellular carcinoma in relation to urokinasetype plasminogen activator, its receptor and inhibitor. J Cancer Res Clin Oncol 2000;126:641-646.
14. Keleg S, Buchler P, Ludwig R, Buchler MW, Friess H. Invasion and metastasis in pancreatic cancer. Mol Cancer 2003;2:14.
15. Lakka SS,Rajagopal R, Rajan MK, et al.Adenovirus-mediated antisense urokinase-type plasminogen activator receptor gene transfer reduces tumor cell invasion and metastasis in non-small cell lung cancer cell lines. Clin Cancer Res 2001;7:1087-1093.
16. Kita Y, Fukagawa T, Mimori K, et al. Expression of uPARmRNA in peripheral blood is a favourite marker for metastasis in gastric cancer cases. Br J Cancer 2009;100:153-159.
17. Huang B, Xu YY. Effect of uPAR on invasion and metastasis of nasopharynal carcinoma (NPC). Pract J Cancer 2004;19:58- 60.
18. Illemann M, Bird N, Majeed A, et al. Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases. Int J Cancer 2009;124:1860-1870.
19. Hildenbrand R, Schaaf A. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Int J Oncol 2009;34:15-23.